<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20241007161209&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20241007161209&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Mon, 07 Oct 2024 20:12:10 +0000</lastbuilddate>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Our Collective Role in Cardiovascular Advocacy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39373687/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 29:S0735-1097(24)08458-4. doi: 10.1016/j.jacc.2024.09.008. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39373687/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39373687</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.008>10.1016/j.jacc.2024.09.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39373687</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Cathleen Biga</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Our Collective Role in Cardiovascular Advocacy</dc:title>
<dc:identifier>pmid:39373687</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.008</dc:identifier>
</item>
<item>
<title>Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39371020/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The current study did not detect superiority of cryoballoon-guided LAAI over low-voltage area ablation in patients with atrial fibrillation despite durable PVI.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 7. doi: 10.1161/CIRCULATIONAHA.124.069993. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Ablation strategies for patients with symptomatic atrial fibrillation and isolated pulmonary veins vary and their effects on arrhythmia recurrence remain unclear. A prospective randomized German multicenter trial sought to compare 2 ablation strategies in this patient cohort.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Patients with atrial fibrillation despite durable pulmonary vein isolation were randomly assigned at 7 centers to undergo low-voltage area ablation using 3-dimensional mapping and irrigated radiofrequency current ablation (group A) or empirical left atrial appendage isolation (LAAI) using the cryoballoon followed by staged interventional left atrial appendage closure (group B). The primary end point was freedom from atrial tachyarrhythmias between 91 and 365 days after index ablation. The study was powered for superiority of LAAI compared with low-voltage area.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Patients (40% women; mean age, 68.8±8 years) with paroxysmal (32%) or persistent atrial fibrillation (68%) were randomized to undergo low-voltage area ablation (n=79) or cryoballoon-guided LAAI (n=82). After a planned interim analysis, enrollment was halted for futility on January 10, 2023. In the LAAI group, 77 of 82 left atrial appendages were successfully isolated with subsequent left atrial appendage closure in 57 patients. Procedure-related complications occurred in 4 (5%) and 11 (13.5%) patients in group A and B, respectively (<i>P</i>=0.10). The median follow-up was 367 days (interquartile range, 359-378). The Kaplan-Meier point estimate for freedom from atrial tachyarrhythmias was 51.7% (CI, 40.9%-65.4%) for group A and 55.5% (CI, 44.4%-69.2%; <i>P</i>=0.8069) for group B.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The current study did not detect superiority of cryoballoon-guided LAAI over low-voltage area ablation in patients with atrial fibrillation despite durable PVI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04056390.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39371020/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39371020</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069993>10.1161/CIRCULATIONAHA.124.069993</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39371020</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Boris Schmidt</dc:creator>
<dc:creator>Stefano Bordignon</dc:creator>
<dc:creator>Andreas Metzner</dc:creator>
<dc:creator>Philipp Sommer</dc:creator>
<dc:creator>Daniel Steven</dc:creator>
<dc:creator>Tilmann Dahme</dc:creator>
<dc:creator>Matthias Busch</dc:creator>
<dc:creator>Roland Richard Tilz</dc:creator>
<dc:creator>David Schaack</dc:creator>
<dc:creator>Andreas Rillig</dc:creator>
<dc:creator>Christian Sohns</dc:creator>
<dc:creator>Arian Sultan</dc:creator>
<dc:creator>Karolina Weinmann-Emhardt</dc:creator>
<dc:creator>Astrid Hummel</dc:creator>
<dc:creator>Julia Vogler</dc:creator>
<dc:creator>Thomas Fink</dc:creator>
<dc:creator>Jakob Lueker</dc:creator>
<dc:creator>Alexander Pott</dc:creator>
<dc:creator>Christian Heeger</dc:creator>
<dc:creator>K-R Julian Chun</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial</dc:title>
<dc:identifier>pmid:39371020</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069993</dc:identifier>
</item>
<item>
<title>Identifying specific functional roles for senescence across cell types</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39368477/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>Cellular senescence plays critical roles in aging, regeneration, and disease; yet, the ability to discern its contributions across various cell types to these biological processes remains limited. In this study, we generated an in vivo genetic toolbox consisting of three p16^(Ink4a)-related intersectional genetic systems, enabling pulse-chase tracing (Sn-pTracer), Cre-based tracing and ablation (Sn-cTracer), and gene manipulation combined with tracing (Sn-gTracer) of defined p16^(Ink4a+) cell...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 1:S0092-8674(24)01069-9. doi: 10.1016/j.cell.2024.09.021. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cellular senescence plays critical roles in aging, regeneration, and disease; yet, the ability to discern its contributions across various cell types to these biological processes remains limited. In this study, we generated an in vivo genetic toolbox consisting of three p16<sup>Ink4a</sup>-related intersectional genetic systems, enabling pulse-chase tracing (Sn-pTracer), Cre-based tracing and ablation (Sn-cTracer), and gene manipulation combined with tracing (Sn-gTracer) of defined p16<sup>Ink4a+</sup> cell types. Using liver injury and repair as an example, we found that macrophages and endothelial cells (ECs) represent distinct senescent cell populations with different fates and functions during liver fibrosis and repair. Notably, clearance of p16<sup>Ink4a+</sup> macrophages significantly mitigates hepatocellular damage, whereas eliminating p16<sup>Ink4a+</sup> ECs aggravates liver injury. Additionally, targeted reprogramming of p16<sup>Ink4a+</sup> ECs through Kdr overexpression markedly reduces liver fibrosis. This study illuminates the functional diversity of p16<sup>Ink4a+</sup> cells and offers insights for developing cell-type-specific senolytic therapies in the future.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39368477/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39368477</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.021>10.1016/j.cell.2024.09.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39368477</guid>
<pubDate>Sat, 05 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Huan Zhao</dc:creator>
<dc:creator>Zixin Liu</dc:creator>
<dc:creator>Hui Chen</dc:creator>
<dc:creator>Maoying Han</dc:creator>
<dc:creator>Mingjun Zhang</dc:creator>
<dc:creator>Kuo Liu</dc:creator>
<dc:creator>Hengwei Jin</dc:creator>
<dc:creator>Xiuxiu Liu</dc:creator>
<dc:creator>Mengyang Shi</dc:creator>
<dc:creator>Wenjuan Pu</dc:creator>
<dc:creator>Markus Werner</dc:creator>
<dc:creator>Michael Meister</dc:creator>
<dc:creator>Stefan G Kauschke</dc:creator>
<dc:creator>Ruilin Sun</dc:creator>
<dc:creator>Jinjin Wang</dc:creator>
<dc:creator>Ruling Shen</dc:creator>
<dc:creator>Qing-Dong Wang</dc:creator>
<dc:creator>Xin Ma</dc:creator>
<dc:creator>Jan S Tchorz</dc:creator>
<dc:creator>Bin Zhou</dc:creator>
<dc:date>2024-10-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Identifying specific functional roles for senescence across cell types</dc:title>
<dc:identifier>pmid:39368477</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.021</dc:identifier>
</item>
<item>
<title>A protein blueprint of the diatom CO&lt;sub>;2&lt;/sub>;-fixing organelle</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39368476/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>Diatoms are central to the global carbon cycle. At the heart of diatom carbon fixation is an overlooked organelle called the pyrenoid, where concentrated CO(2) is delivered to densely packed Rubisco. Diatom pyrenoids fix approximately one-fifth of global CO(2), but the protein composition of this organelle is largely unknown. Using fluorescence protein tagging and affinity purification-mass spectrometry, we generate a high-confidence spatially defined protein-protein interaction network for the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 3:S0092-8674(24)01073-0. doi: 10.1016/j.cell.2024.09.025. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Diatoms are central to the global carbon cycle. At the heart of diatom carbon fixation is an overlooked organelle called the pyrenoid, where concentrated CO<sub>2</sub> is delivered to densely packed Rubisco. Diatom pyrenoids fix approximately one-fifth of global CO<sub>2</sub>, but the protein composition of this organelle is largely unknown. Using fluorescence protein tagging and affinity purification-mass spectrometry, we generate a high-confidence spatially defined protein-protein interaction network for the diatom pyrenoid. Within our pyrenoid interaction network are 10 proteins with previously unknown functions. We show that six of these form a shell that encapsulates the Rubisco matrix and is critical for pyrenoid structural integrity, shape, and function. Although not conserved at a sequence or structural level, the diatom pyrenoid shares some architectural similarities to prokaryotic carboxysomes. Collectively, our results support the convergent evolution of pyrenoids across the two main plastid lineages and uncover a major structural and functional component of global CO<sub>2</sub> fixation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39368476/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39368476</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.025>10.1016/j.cell.2024.09.025</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39368476</guid>
<pubDate>Sat, 05 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Onyou Nam</dc:creator>
<dc:creator>Sabina Musiał</dc:creator>
<dc:creator>Manon Demulder</dc:creator>
<dc:creator>Caroline McKenzie</dc:creator>
<dc:creator>Adam Dowle</dc:creator>
<dc:creator>Matthew Dowson</dc:creator>
<dc:creator>James Barrett</dc:creator>
<dc:creator>James N Blaza</dc:creator>
<dc:creator>Benjamin D Engel</dc:creator>
<dc:creator>Luke C M Mackinder</dc:creator>
<dc:date>2024-10-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A protein blueprint of the diatom CO&lt;sub>;2&lt;/sub>;-fixing organelle</dc:title>
<dc:identifier>pmid:39368476</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.025</dc:identifier>
</item>
<item>
<title>A genome-wide spectrum of tandem repeat expansions in 338,963 humans</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39368475/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 4:S0092-8674(24)01145-0. doi: 10.1016/j.cell.2024.09.045. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39368475/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39368475</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.045>10.1016/j.cell.2024.09.045</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39368475</guid>
<pubDate>Sat, 05 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Ya Cui</dc:creator>
<dc:creator>Wenbin Ye</dc:creator>
<dc:creator>Jason Sheng Li</dc:creator>
<dc:creator>Jingyi Jessica Li</dc:creator>
<dc:creator>Eric Vilain</dc:creator>
<dc:creator>Tamer Sallam</dc:creator>
<dc:creator>Wei Li</dc:creator>
<dc:date>2024-10-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A genome-wide spectrum of tandem repeat expansions in 338,963 humans</dc:title>
<dc:identifier>pmid:39368475</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.045</dc:identifier>
</item>
<item>
<title>New light shed on the treatment of heart failure and on novel therapeutic targets</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39367734/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 5;45(37):3775-3779. doi: 10.1093/eurheartj/ehae643.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39367734/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39367734</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae643>10.1093/eurheartj/ehae643</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39367734</guid>
<pubDate>Sat, 05 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-10-05</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>New light shed on the treatment of heart failure and on novel therapeutic targets</dc:title>
<dc:identifier>pmid:39367734</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae643</dc:identifier>
</item>
<item>
<title>Rift Valley fever virus coordinates the assembly of a programmable E3 ligase to promote viral replication</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39366381/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>Viruses encode strategies to degrade cellular proteins to promote infection and pathogenesis. Here, we revealed that the non-structural protein NSs of Rift Valley fever virus forms a filamentous E3 ligase to trigger efficient degradation of targeted proteins. Reconstitution in vitro and cryoelectron microscopy analysis with the 2.9-Å resolution revealed that NSs forms right-handed helical fibrils. The NSs filamentous oligomers associate with the cellular FBXO3 to form a remodeled E3 ligase. The...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Sep 26:S0092-8674(24)01026-2. doi: 10.1016/j.cell.2024.09.008. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Viruses encode strategies to degrade cellular proteins to promote infection and pathogenesis. Here, we revealed that the non-structural protein NSs of Rift Valley fever virus forms a filamentous E3 ligase to trigger efficient degradation of targeted proteins. Reconstitution in vitro and cryoelectron microscopy analysis with the 2.9-Å resolution revealed that NSs forms right-handed helical fibrils. The NSs filamentous oligomers associate with the cellular FBXO3 to form a remodeled E3 ligase. The NSs-FBXO3 E3 ligase targets the cellular TFIIH complex through the NSs-P62 interaction, leading to ubiquitination and proteasome-dependent degradation of the TFIIH complex. NSs-FBXO3-triggered TFIIH complex degradation resulted in robust inhibition of antiviral immunity and promoted viral pathogenesis in vivo. Furthermore, it is demonstrated that NSs can be programmed to target additional proteins for proteasome-dependent degradation, serving as a versatile targeted protein degrader. These results showed that a virulence factor forms a filamentous and programmable degradation machinery to induce organized degradation of cellular proteins to promote viral infection.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39366381/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39366381</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.008>10.1016/j.cell.2024.09.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39366381</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Huiling Li</dc:creator>
<dc:creator>Yulan Zhang</dc:creator>
<dc:creator>Guibo Rao</dc:creator>
<dc:creator>Chongtao Zhang</dc:creator>
<dc:creator>Zhenqiong Guan</dc:creator>
<dc:creator>Ziyan Huang</dc:creator>
<dc:creator>Shufen Li</dc:creator>
<dc:creator>Pierre-Yves Lozach</dc:creator>
<dc:creator>Sheng Cao</dc:creator>
<dc:creator>Ke Peng</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Rift Valley fever virus coordinates the assembly of a programmable E3 ligase to promote viral replication</dc:title>
<dc:identifier>pmid:39366381</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.008</dc:identifier>
</item>
<item>
<title>Cryo-EM vs. Disease X</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39366340/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>In this issue of Cell, Penzes et al. describe the use of cryo-EM to identify the cause of a mysterious disease affecting farmed superworms across the US. The study illustrates the power of ex vivo cryo-EM, which uses amplification-free samples to advance at once diagnostic, DNA packaging mechanism, and preventative measures.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 3;187(20):5497-5499. doi: 10.1016/j.cell.2024.09.002.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In this issue of Cell, Penzes et al. describe the use of cryo-EM to identify the cause of a mysterious disease affecting farmed superworms across the US. The study illustrates the power of ex vivo cryo-EM, which uses amplification-free samples to advance at once diagnostic, DNA packaging mechanism, and preventative measures.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39366340/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39366340</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.002>10.1016/j.cell.2024.09.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39366340</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Fasséli Coulibaly</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Cryo-EM vs. Disease X</dc:title>
<dc:identifier>pmid:39366340</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.002</dc:identifier>
</item>
<item>
<title>A call from patient-researchers to advance research on long COVID</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39366339/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between patients and researchers threaten to hinder future progress. Incorporating patients as active collaborators in long COVID research can bridge the gap and accelerate progress toward treatments and cures.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 3;187(20):5490-5496. doi: 10.1016/j.cell.2024.09.011.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between patients and researchers threaten to hinder future progress. Incorporating patients as active collaborators in long COVID research can bridge the gap and accelerate progress toward treatments and cures.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39366339/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39366339</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.011>10.1016/j.cell.2024.09.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39366339</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Megan L Fitzgerald</dc:creator>
<dc:creator>Alison K Cohen</dc:creator>
<dc:creator>Toni Wall Jaudon</dc:creator>
<dc:creator>Julia Moore Vogel</dc:creator>
<dc:creator>Abigail N Koppes</dc:creator>
<dc:creator>Lucia Santos</dc:creator>
<dc:creator>Rachel Robles</dc:creator>
<dc:creator>Jerry Lin</dc:creator>
<dc:creator>J D Davids</dc:creator>
<dc:creator>Chris McWilliams</dc:creator>
<dc:creator>Signe Redfield</dc:creator>
<dc:creator>Kathleen P Banks</dc:creator>
<dc:creator>Maria Richardson</dc:creator>
<dc:creator>Teresa T Tindle Akintonwa</dc:creator>
<dc:creator>Beth Pollack</dc:creator>
<dc:creator>Ezra Spier</dc:creator>
<dc:creator>Aimee Weiss</dc:creator>
<dc:creator>Gina Assaf</dc:creator>
<dc:creator>Hannah Davis</dc:creator>
<dc:creator>Lisa McCorkell</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A call from patient-researchers to advance research on long COVID</dc:title>
<dc:identifier>pmid:39366339</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.011</dc:identifier>
</item>
<item>
<title>Correction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365640/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 4:ehae701. doi: 10.1093/eurheartj/ehae701. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365640/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365640</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae701>10.1093/eurheartj/ehae701</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365640</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:date>2024-10-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction</dc:title>
<dc:identifier>pmid:39365640</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae701</dc:identifier>
</item>
<item>
<title>A similar severe fibrosis pattern in a monozygotic twin pair with the TRIM63 variant manifesting as hypertrophic cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365612/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 4:ehae607. doi: 10.1093/eurheartj/ehae607. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365612/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365612</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae607>10.1093/eurheartj/ehae607</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365612</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Lutong Pu</dc:creator>
<dc:creator>Jie Wang</dc:creator>
<dc:creator>Yucheng Chen</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A similar severe fibrosis pattern in a monozygotic twin pair with the TRIM63 variant manifesting as hypertrophic cardiomyopathy</dc:title>
<dc:identifier>pmid:39365612</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae607</dc:identifier>
</item>
<item>
<title>The Apple May Fall Far From the Family Tree in Hypertrophic Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365228/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08450-X. doi: 10.1016/j.jacc.2024.08.066. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365228/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365228</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.066>10.1016/j.jacc.2024.08.066</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365228</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Nosheen Reza</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>The Apple May Fall Far From the Family Tree in Hypertrophic Cardiomyopathy</dc:title>
<dc:identifier>pmid:39365228</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.066</dc:identifier>
</item>
<item>
<title>Prevalence and Impact of Recurrent Rejection on Pediatric Heart Transplant Recipients: A PHTS Multi-Institutional Analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365227/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Although prevalence of RR has decreased, children experiencing RR are at greatly increased risk for losing their graft, particularly those who have recurrent mixed or antibody-mediated rejection.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08160-9. doi: 10.1016/j.jacc.2024.08.010. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Studies evaluating the prevalence and impact of recurrent rejection (RR) in pediatric heart transplant (HT) are sparse.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The purpose of this study was to describe prevalence and impact of RR on cardiac allograft vasculopathy (CAV) and graft loss after pediatric HT.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Data on HT from January 1, 2000, to June 30, 2020, in the Pediatric Heart Transplant Society database were included. Freedom from RR (≥2 rejection episodes) was compared by era (early: 2000-2009; current: 2010-2020). Outcomes for children experiencing RR were compared with those experiencing 0 or 1 rejection episodes and by type of RR (antibody-mediated rejection [AMR], acute cellular rejection [ACR], mixed [ACR/AMR]).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 6,342 HT recipients, 1,035 (17%) experienced RR. In the current era, pediatric HT recipients were less likely to experience RR (P &lt; 0.001). Freedom from CAV was similar for those experiencing RR to those experiencing 0 or 1 episode (96.6% vs 95.3% vs 96.6%); and similar regardless of the type of RR (AMR, ACR, or mixed) (65.5% vs 82.9% vs 100%) (P >; 0.05). Freedom from graft loss was significantly lower for those experiencing RR to those experiencing 0 or 1 episode (56.3% vs 72.3% vs 82.3%) and lower for those experiencing recurrent mixed rejection or recurrent AMR compared with those experiencing recurrent ACR (65.3% vs 50% vs 81.8%). Black children experiencing RR subsequently had lower freedom from CAV and graft loss than White children (P &lt; 0.05 for all).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Although prevalence of RR has decreased, children experiencing RR are at greatly increased risk for losing their graft, particularly those who have recurrent mixed or antibody-mediated rejection.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365227/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365227</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.010>10.1016/j.jacc.2024.08.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365227</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Shahnawaz Amdani</dc:creator>
<dc:creator>James K Kirklin</dc:creator>
<dc:creator>Ryan Cantor</dc:creator>
<dc:creator>Devin Koehl</dc:creator>
<dc:creator>Ashwin Lal</dc:creator>
<dc:creator>Peter Chau</dc:creator>
<dc:creator>Valerie Curren</dc:creator>
<dc:creator>Jonathan B Edelson</dc:creator>
<dc:creator>John J Parent</dc:creator>
<dc:creator>Hannah Victor</dc:creator>
<dc:creator>Ali Burnette</dc:creator>
<dc:creator>Jacqueline M Lamour</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Prevalence and Impact of Recurrent Rejection on Pediatric Heart Transplant Recipients: A PHTS Multi-Institutional Analysis</dc:title>
<dc:identifier>pmid:39365227</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.010</dc:identifier>
</item>
<item>
<title>Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365226/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The present study represents the most comprehensive (>;7,000 proteins) and largest-scale (n = 99 HCM cases) proteomic profiling of human HCM myocardium to date. Proteomic profiling and confirmatory transcriptomic profiling elucidate dysregulation of both newly recognized (eg, Ras-mitogen-activated protein kinase) and known pathways associated with pathogenesis and progression to severe forms of HCM.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08159-2. doi: 10.1016/j.jacc.2024.07.043. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiac disease. Signaling pathways that link genetic sequence variants to clinically overt HCM and progression to severe forms of HCM remain unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The purpose of this study was to identify signaling pathways that are differentially regulated in HCM, using proteomic profiling of human myocardium, confirmed with transcriptomic profiling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this multicenter case-control study, myocardial samples were obtained from cases with HCM and control subjects with nonfailing hearts. Proteomic profiling of 7,289 proteins from myocardial samples was performed using the SomaScan assay (SomaLogic). Pathway analysis of differentially expressed proteins was performed, using a false discovery rate &lt;0.05. Pathway analysis of proteins whose concentrations correlated with clinical indicators of severe HCM (eg, reduced left ventricular ejection fraction, atrial fibrillation, and ventricular tachyarrhythmias) was also executed. Confirmatory analysis of differentially expressed genes was performed using myocardial transcriptomic profiling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The study included 99 HCM cases and 15 control subjects. Pathway analysis of differentially expressed proteins revealed dysregulation of the Ras-mitogen-activated protein kinase, ubiquitin-mediated proteolysis, angiogenesis-related (eg, hypoxia-inducible factor-1, vascular endothelial growth factor), and Hippo pathways. Pathways known to be dysregulated in HCM, including metabolic, inflammatory, and extracellular matrix pathways, were also dysregulated. Pathway analysis of proteins associated with clinical indicators of severe HCM and of differentially expressed genes supported these findings.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The present study represents the most comprehensive (>;7,000 proteins) and largest-scale (n = 99 HCM cases) proteomic profiling of human HCM myocardium to date. Proteomic profiling and confirmatory transcriptomic profiling elucidate dysregulation of both newly recognized (eg, Ras-mitogen-activated protein kinase) and known pathways associated with pathogenesis and progression to severe forms of HCM.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365226/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365226</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.07.043>10.1016/j.jacc.2024.07.043</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365226</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Heidi S Lumish</dc:creator>
<dc:creator>Mark V Sherrid</dc:creator>
<dc:creator>Paul M L Janssen</dc:creator>
<dc:creator>Giovanni Ferrari</dc:creator>
<dc:creator>Kohei Hasegawa</dc:creator>
<dc:creator>Estibaliz Castillero</dc:creator>
<dc:creator>Elizabeth Adlestein</dc:creator>
<dc:creator>Daniel G Swistel</dc:creator>
<dc:creator>Veli K Topkara</dc:creator>
<dc:creator>Mathew S Maurer</dc:creator>
<dc:creator>Muredach P Reilly</dc:creator>
<dc:creator>Yuichi J Shimada</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy</dc:title>
<dc:identifier>pmid:39365226</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.07.043</dc:identifier>
</item>
<item>
<title>Proteomic Profiling: The Key to Unlocking the Complexities of Hypertrophic Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365225/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08461-4. doi: 10.1016/j.jacc.2024.08.071. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365225/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365225</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.071>10.1016/j.jacc.2024.08.071</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365225</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Sakthivel Sadayappan</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Proteomic Profiling: The Key to Unlocking the Complexities of Hypertrophic Cardiomyopathy</dc:title>
<dc:identifier>pmid:39365225</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.071</dc:identifier>
</item>
<item>
<title>Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365224/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In HCM, the diagnostic yield of a single screening visit was 1 in 4, and the additional yield during 7 years of follow-up was 4%. Gene carriers and relatives from gene-elusive families with a baseline MWT of ≥10 mm were at the highest risk of developing HCM during follow-up. These findings may inform future recommendations on the management of relatives of HCM patients.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08161-0. doi: 10.1016/j.jacc.2024.08.011. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disease, and clinical and genetic family screening is recommended by guidelines.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study sought to investigate the diagnostic yield of screening relatives of HCM patients and identify predictive factors for HCM development during long-term follow-up in relatives from gene-elusive families.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a retrospective cohort study of families screened at clinics for inherited cardiomyopathies in Eastern Denmark, from 2006 to 2023.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We included 1,230 relatives (55% female; age: 42 ± 17 years) from 531 families. The combined clinical and genetic yield at baseline was 26% (n = 321). After 7 years (mean) of follow-up (6,762 person-years), 43 (4%) additional relatives developed HCM. The strongest predictors of developing HCM were carrying a likely pathogenic/pathogenic variant (HR: 4.58; 95% CI: 2.50-8.40; P &lt; 0.001) and larger left ventricular maximum wall thickness (MWT) (HR: 2.21 per mm; 95% CI: 1.76-2.77 per mm; P &lt; 0.001). In gene-elusive families, we found that an MWT of ≥10 mm represented the optimal classification threshold for developing HCM (area under the curve: 0.80), with only 2 (0.4%) relatives from gene-elusive families with an MWT of &lt;10 mm developing HCM during follow-up.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In HCM, the diagnostic yield of a single screening visit was 1 in 4, and the additional yield during 7 years of follow-up was 4%. Gene carriers and relatives from gene-elusive families with a baseline MWT of ≥10 mm were at the highest risk of developing HCM during follow-up. These findings may inform future recommendations on the management of relatives of HCM patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365224/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365224</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.011>10.1016/j.jacc.2024.08.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365224</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Elvira Silajdzija</dc:creator>
<dc:creator>Christoffer Rasmus Vissing</dc:creator>
<dc:creator>Emma Basse Christensen</dc:creator>
<dc:creator>Helen Lamiokor Mills</dc:creator>
<dc:creator>Thilde Olivia Kock</dc:creator>
<dc:creator>Lars Juel Andersen</dc:creator>
<dc:creator>Martin Snoer</dc:creator>
<dc:creator>Jens Jakob Thune</dc:creator>
<dc:creator>Emil Daniel Bartels</dc:creator>
<dc:creator>Anna Axelsson Raja</dc:creator>
<dc:creator>Alex Hørby Christensen</dc:creator>
<dc:creator>Henning Bundgaard</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up</dc:title>
<dc:identifier>pmid:39365224</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.011</dc:identifier>
</item>
<item>
<title>Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365223/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08165-8. doi: 10.1016/j.jacc.2024.08.013. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365223/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365223</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.013>10.1016/j.jacc.2024.08.013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365223</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Alessia Di Costanzo</dc:creator>
<dc:creator>Ilaria Pirona</dc:creator>
<dc:creator>Silvia Buonaiuto</dc:creator>
<dc:creator>Laura D'Erasmo</dc:creator>
<dc:creator>Simone Bini</dc:creator>
<dc:creator>Daniele Tramontano</dc:creator>
<dc:creator>Stella Covino</dc:creator>
<dc:creator>Carlo Maiorca</dc:creator>
<dc:creator>Ilenia Minicocci</dc:creator>
<dc:creator>Marialuisa Sponziello</dc:creator>
<dc:creator>Francesco Baratta</dc:creator>
<dc:creator>Daniela Commodari</dc:creator>
<dc:creator>Vincenza Colonna</dc:creator>
<dc:creator>Allegra Via</dc:creator>
<dc:creator>Marcello Arca</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease</dc:title>
<dc:identifier>pmid:39365223</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.013</dc:identifier>
</item>
<item>
<title>Applying Clinical Risk Scores in Real-World Practice: The CHA&lt;sub>;2&lt;/sub>;DS&lt;sub>;2&lt;/sub>;-VASc Score in Atrial Fibrillation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365222/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08169-5. doi: 10.1016/j.jacc.2024.08.017. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365222/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365222</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.017>10.1016/j.jacc.2024.08.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365222</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Geoffrey D Barnes</dc:creator>
<dc:creator>Gregory Y H Lip</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Applying Clinical Risk Scores in Real-World Practice: The CHA&lt;sub>;2&lt;/sub>;DS&lt;sub>;2&lt;/sub>;-VASc Score in Atrial Fibrillation</dc:title>
<dc:identifier>pmid:39365222</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.017</dc:identifier>
</item>
<item>
<title>Hit Differently: Disparities Persist in Recurrent Rejection After Pediatric Heart Transplant</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365221/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08384-0. doi: 10.1016/j.jacc.2024.09.001. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365221/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39365221</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.001>10.1016/j.jacc.2024.09.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365221</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Amanda D McCormick</dc:creator>
<dc:creator>David M Peng</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Hit Differently: Disparities Persist in Recurrent Rejection After Pediatric Heart Transplant</dc:title>
<dc:identifier>pmid:39365221</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.001</dc:identifier>
</item>
<item>
<title>Acute Alcohol Consumption and Arrhythmias in Young Adults: The MunichBREW II Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39363568/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The study demonstrates the impact of binge drinking on heart rate alterations and increased atrial tachycardias during 'drinking period', and the occurrence of clinically relevant arrythmias during the 'recovery period', emphasizing the holiday heart syndrome as a health concern.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 4:ehae695. doi: 10.1093/eurheartj/ehae695. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: and aims: Acute excessive alcohol intake may cause the holiday heart syndrome, characterized by cardiac arrhythmias including atrial fibrillation. Since underlying data are scarce, the study aimed to prospectively investigate the temporal course of occurring cardiac arrhythmias following binge drinking in young adults.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A total of 202 volunteers planning acute alcohol consumption with expected peak breath alcohol concentrations (BAC) of ≥1.2 g/kg were enrolled. The study comprised 48-hour electrocardiogram (ECG) monitoring covering baseline (hour 0), 'drinking period' (hours 1-5), 'recovery period' (hours 6-19), and two control periods corresponding to 24 hours after the 'drinking' and 'recovery periods', respectively. Acute alcohol intake was monitored by BAC measurements during the 'drinking period'. ECGs were analyzed for mean heart rate, atrial tachycardia, premature atrial complexes (PAC), premature ventricular complexes (PVC), and heart rate variability (HRV) measures.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Data revealed an increase in heart rate and an excess of atrial tachycardias with increasing alcohol intake. HRV analysis indicated an autonomic modulation with sympathetic activation during alcohol consumption and the subsequent 'recovery period', followed by parasympathetic predominance thereafter. PACs occurred significantly more frequently in the 'control periods', whereas PVCs were more frequent in the 'drinking period'. Ten participants experienced notable arrhythmic episodes, including atrial fibrillation and ventricular tachycardias, primarily during the 'recovery period'.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The study demonstrates the impact of binge drinking on heart rate alterations and increased atrial tachycardias during 'drinking period', and the occurrence of clinically relevant arrythmias during the 'recovery period', emphasizing the holiday heart syndrome as a health concern.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39363568/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39363568</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae695>10.1093/eurheartj/ehae695</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39363568</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Stefan Brunner</dc:creator>
<dc:creator>Christina Krewitz</dc:creator>
<dc:creator>Raphaela Winter</dc:creator>
<dc:creator>Aenne S von Falkenhausen</dc:creator>
<dc:creator>Anna Kern</dc:creator>
<dc:creator>Dorothee Brunner</dc:creator>
<dc:creator>Moritz F Sinner</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Acute Alcohol Consumption and Arrhythmias in Young Adults: The MunichBREW II Study</dc:title>
<dc:identifier>pmid:39363568</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae695</dc:identifier>
</item>
<item>
<title>Private information leakage from single-cell count matrices</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39362221/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241007161209&amp;v=2.18.0.post9+e462414
      <description>The increase in publicly available human single-cell datasets, encompassing millions of cells from many donors, has significantly enhanced our understanding of complex biological processes. However, the accessibility of these datasets raises significant privacy concerns. Due to the inherent noise in single-cell measurements and the scarcity of population-scale single-cell datasets, recent private information quantification studies have focused on bulk gene expression data sharing. To address...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Sep 27:S0092-8674(24)01030-4. doi: 10.1016/j.cell.2024.09.012. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The increase in publicly available human single-cell datasets, encompassing millions of cells from many donors, has significantly enhanced our understanding of complex biological processes. However, the accessibility of these datasets raises significant privacy concerns. Due to the inherent noise in single-cell measurements and the scarcity of population-scale single-cell datasets, recent private information quantification studies have focused on bulk gene expression data sharing. To address this gap, we demonstrate that individuals in single-cell gene expression datasets are vulnerable to linking attacks, where attackers can infer their sensitive phenotypic information using publicly available tissue or cell-type-specific expression quantitative trait loci (eQTLs) information. We further develop a method for genotype prediction and genotype-phenotype linking that remains effective without relying on eQTL information. We show that variants from one study can be exploited to uncover private information about individuals in another study.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39362221/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241007161209&v=2.18.0.post9+e462414">39362221</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.012>10.1016/j.cell.2024.09.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39362221</guid>
<pubDate>Thu, 03 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Conor R Walker</dc:creator>
<dc:creator>Xiaoting Li</dc:creator>
<dc:creator>Manav Chakravarthy</dc:creator>
<dc:creator>William Lounsbery-Scaife</dc:creator>
<dc:creator>Yoolim A Choi</dc:creator>
<dc:creator>Ritambhara Singh</dc:creator>
<dc:creator>Gamze Gürsoy</dc:creator>
<dc:date>2024-10-03</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Private information leakage from single-cell count matrices</dc:title>
<dc:identifier>pmid:39362221</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.012</dc:identifier>
</item>





























</channel>
</rss>